{"id":702,"date":"2018-03-19T16:12:14","date_gmt":"2018-03-19T16:12:14","guid":{"rendered":"http:\/\/joshmitteldorf.peachpuff-wolverine-566518.hostingersite.com\/?p=702"},"modified":"2018-03-20T11:09:02","modified_gmt":"2018-03-20T11:09:02","slug":"telomerase-update-and-downgrade","status":"publish","type":"post","link":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/","title":{"rendered":"Telomerase: Update and Downgrade"},"content":{"rendered":"

I have been enthusiastic about telomerase therapies for anti-aging since 2003. \u00a0But if I can\u2019t change my mind as new data appears, what\u2019s the point of being a scientist? \u00a0I still believe that lengthening telomeres is a net benefit, but the potential for added years is modest, and there are probably risks and tradeoffs. \u00a0The study that has most influenced me is <\/span><\/i>this one<\/span><\/i><\/a>, implying that telomerase affects epigenetics (through methylation) in ways that accelerate aging. \u00a0My theory is that the unexpected relationship between telomerase and methylation is an example of antagonistic pleiotropy, but pleiotropy in a very different sense from the standard evolutionary theory.<\/span><\/i><\/p>\n

\n

Do people with longer telomeres have longer life expectancy? In 2003, Richard Cawthon of University of Utah first addressed this question experimentally with a <\/span>study<\/span><\/a> that was clever, innovative and courageous. \u00a0It was innovative in that he <\/span>introduced<\/span><\/a> a fast and convenient way to measure telomere length from very small quantities of DNA, using the Polymerase Chain Reaction<\/a>. \u00a0It was clever in that, instead of a \u201cprospective study\u201d measuring telomere length in his subjects and then following 20 years to see what would happen to them, he did the experiment retrospectively, using historic samples of blood that had been taken from people twenty years earlier and kept in frozen storage by a local hospital. \u00a0And it was courageous in that everyone believed at the time that extending life could not be so easy as just lengthening telomeres, or else the body would already be doing it! That is to say, no one would fund the study because they thought they knew how it had to come out.<\/span><\/p>\n

But they were wrong. \u00a0Even with Cawthon\u2019s small sample of only 143 subjects, the relationship between telomere length and diseases of old age jumped out of the statistics. \u00a0The quartile with the shortest telomeres had suffered two times higher mortality and three times greater incidence of heart disease in the intervening 20 years than those with the longest telomeres.<\/span><\/p>\n

Red blood cells have no DNA, hence no telomeres, but white blood cells are constantly dividing to target specific bacterial, so the telomeres in white blood cells are a sensitive measure of immune health. \u00a0Cawthon reported that the group with shortest telomeres had suffered 9 times the rate of infectious disease compared to the longest telomere group.<\/span><\/p>\n

At the time of Cawthon\u2019s study, there was a great deal of skepticism, based purely on theory. \u00a0The standard hypothesis was that all animals are evolved to live as long as possible, all else being equal, and if telomerase were being held back, there must be a powerful downside associated with it.\u00a0 I was already marching to the beat of a different drummer in 2003, and I didn\u2019t believe that evolution was always going for the longest lifespan available. Because I believe that aging is an evolutionary program, it was easy for me to see telomere shortening as part of the program. \u00a0The biggest clue in my mind was the evolutionary origin of telomere shortening in single-celled protozoans. In the ciliates (e.g. paramecium), telomerase is not expressed in <\/span>mitosis<\/span><\/a> (when the cell copies itself), but only when it <\/span>conjugates <\/span><\/a>(recombining genes with other individuals) with another. \u00a0Hence, a cell that just goes on reproducing as fast as possible without sharing its genes was doomed to die of cell senescence.\u00a0 A billion years ago, telomeres were already a means of enforcing the communal imperative, Share your genes!\u00a0 It is easy to imagine that the same evolutionary imperative has persisted through the aeons, and that telomere shortening insures death in many higher organisms. \u00a0Indeed, since Cawthon, it has been demonstrated that short telomeres are a mode of aging in dogs, cats, and horses, (but not cows, pigs or mice).<\/span><\/p>\n

Three years ago, <\/span>I reported<\/span><\/a> on a <\/span>Danish study<\/span><\/a> that replicated Cawthon\u2019s results on a huge scale. \u00a0In 60,000 subjects, Rode associated short telomeres with all-cause mortality, heart disease, diabetes, and some cancers.<\/span><\/p>\n

Telomere shortening leads to senescence and higher disease risk by three known mechanisms. \u00a0First, stem cells with the shortest telomeres stop reproducing, hence the body\u2019s tissues don\u2019t renew as efficiently. \u00a0Second, senescent cells are not just dead weight, they actually emit chemical signals (<\/span>cytokines<\/span><\/a>) that increase inflammation. \u00a0This has been called SASP, for <\/span>Senescence-Associated Secretory Phenotype<\/span><\/a>.) \u00a0Third, senescence in the bone marrow that generates new white blood cells is especially damaging to the immune system, because it prevents the body from responding effectively when challenged with new infections.<\/span><\/p>\n

 <\/p>\n

Telomeres and cancer<\/b><\/p>\n

If short telomeres cause all these problems, why would the body ever allow its telomeres to become short? \u00a0It was recognized early in the game that production of telomerase entails no substantial metabolic cost, so the question challenges the conventional theory that individual animals are evolved to live as long as possible.\u00a0 Of course, for us who believe that aging is programmed, there is no problem with this.\u00a0 But the first suggestion of an answer within the conventional paradigm came from <\/span>Carol Greider<\/span><\/a>, one of the original discoverers of telomerase, and independently from <\/span>Ruth Sager<\/span><\/a>. \u00a0Telomerase is needed to make cells immortal. \u00a090% of cancer cells have found ways to bypass the suppression of telomerase in order to continue proliferating unabated. \u00a0Greider and Sager proposed that keeping telomerase under lock and key constitutes one of the barriers that keeps cells from going rogue as tumors. \u00a0Telomere shortening helps to prevent cancer.<\/span><\/p>\n

This argument never made any sense to me. \u00a0First, what good was it to suppress cancer if the net effect was to shorten lifespan? \u00a0And second, I believe that the body\u2019s principal defense against cancer is the immune system, and if short telomeres can cripple the immune system, that was likely to do more to promote cancer than to prevent it.<\/span><\/p>\n

Nevertheless, the idea that telomerase is rationed to protect against cancer persisted in the biomedical community for 20 years based on theory alone, even as it was <\/span>moderated by the discovery of SASP<\/span><\/a>.<\/span><\/p>\n

\"\"<\/p>\n

Experimental link between telomeres and cancer<\/b><\/p>\n

I came into this field <\/span>very skeptical<\/span><\/a> of the idea that long telomeres could cause cancer. \u00a0But as the evidence has accumulated, I\u2019m compelled to reconsider. \u00a0Just last summer, I <\/span>blogged critically<\/span><\/a> about the largest genetic study to date, linking genetic predisposition for longer telomeres with cancer rates later in life. \u00a0I noted that the measured effect is actually quite small, but is reported blown up to alarming proportions by exponential extrapolation. \u00a0But that didn\u2019t mean it was necessarily wrong, only that it was unconvincing. Shortly afterward, I became aware of observational studies, based on measured telomere length rather than the genetic predisposition. \u00a0These are harder to refute.<\/span><\/p>\n

In <\/span>this study<\/span><\/a> from the Moffitt Cancer Center, short telomeres (as measured directly, not imputed from genetic variation) are associated with higher risk of squamous cell skin cancer, but long telomeres are associated with higher risk of melanoma skin cancer. \u00a0Same methodology, same authors. Why would I believe one and disbelieve the other? Melanoma tends to occur at younger ages than squamous cell carcinoma, this supporting the Greider hypothesis that telomere shortening should be especially important for cancer prevention while we are still in a fertile stage of life. \u00a0The Moffitt results on melanoma were confirming a finding <\/span>reported earlier<\/span><\/a> from Harvard Med School. \u00a0<\/span><\/p>\n

In <\/span>this study<\/span><\/a>, people with the longest telomeres had nearly twice the risk of lung cancer compared to people with short telomeres, after adjustment for age and smoking status. \u00a0There are 25 co-authors, and Cawthon is #2. In <\/span>this study<\/span><\/a>, short telomeres protect against (devastatingly lethal) pancreatic cancer, and in <\/span>this one<\/span><\/a>, there is an elevated risk of breast cancer associated with long telomeres.<\/span><\/p>\n

There are studies contradicting each of these findings. \u00a0Overall, the field seems to be more of a confused mess even than most areas of epidemiology. \u00a0But for lung cancer, melanoma, and pancreatic cancer, the predominance of the evidence says that longer telomeres are associated with higher risk.<\/span><\/p>\n

Longer telomeres uncontroversially protect against heart disease and stroke. \u00a0There is no contradiction of this finding in sight, and there has been no contradiction of the major finding (by <\/span>Rode<\/span><\/a> and <\/span>Cawthon<\/span><\/a>) that short telomeres increase all-cause mortality. \u00a0Perhaps that\u2019s all we need to know.<\/span><\/p>\n

 <\/p>\n

Stop the Presses<\/b><\/p>\n

Just a few weeks ago, I learned of <\/span>this new study<\/span><\/a> linking telomerase to the epigenetic changes that the methylation clock associates with aging. \u00a0The implication is that telomerase accelerates aging. It began with an investigation by Steve Horvath\u2019s group (about which <\/span>I reported last month<\/span><\/a>) asking, what genetic variations are associated with people who age faster or slower than average, according to the Horvath methylation clock? \u00a0They did a genome-wide search for statistical correlates and the standout association was telomerase. People who have small genetic variations that support greater telomerase expression tend to have longer telomeres, but they also tend to age faster, as measured by the Horvath clock.<\/span><\/p>\n

It\u2019s been known for a long time that <\/span>telomerase has other effects<\/span><\/a> in addition to lengthening telomeres. \u00a0But this is the first time that telomerase has been reported to affect DNA methylation. \u00a0So it seems we are presented with a tradeoff, or pleiotropy, or Catch-22, or \u201cdamned if you do, damned if you don\u2019t.\u201d<\/span><\/p>\n

The association between telomerase and accelerated aging (measured by methylation) was found in the genetic statistics, and then confirmed in a cell culture. \u00a0When telomerase was artificially activated in the cell culture, the methylation patterns changed in the cells consistent with older age according to the Horvath clock. \u00a0In fact (and remarkably in my opinion) they found no Horvath aging at all in the cell cultures that lacked telomerase<\/em><\/strong>. Could it be that telomerase is the one and only driver of epigenetic aging at the cellular level?<\/span><\/p>\n

Telomere length and the Horvath methylation clock are both correlated with age, but they are not otherwise correlated with each other. \u00a0The Horvath clock is a combination of 353 methylation levels that is optimized to correlate maximally with age. The observed correlation is 0.95. \u00a0Telomere length is not statistically optimized but measured as nature offers it, and its correlation is much weaker (~0.4 according to my estimate, as I have not found this number in print). \u00a0Thus Horvath clock is an excellent measure of chronological age, and combining information about telomere length can make it potentially a little more accurate yet.\u00a0 But the telomere clock on its own is a very unreliable measure of age.<\/span><\/p>\n

The Horvath group designed an experiment \u00a0to separate the direct effect of telomerase on methylation from an indirect effect (telomerase \u21d2 telomere length \u21d2 methylation age). \u00a0They found no indirect effect. Telomerase itself affects methylation aging, but telomere length does not. <\/span><\/p>\n

This raises (what is for me) an uncomfortable question. \u00a0Many \u201cgood\u201d life habits have been associated with telomerase expression, including exercise, meditation, and social integration. \u00a0Could it be that these habits are simultaneously slowing our telomere aging, while hastening our epigenetic aging?<\/span><\/p>\n

\u201cWhile the paradoxical finding cannot be disputed on scientific grounds, its biological interpretation remains to be elucidated.\u201d [<\/span>Lu et. al, 2018<\/span><\/a>, the same study I\u2019ve been talking about]<\/span><\/p>\n

(Another finding of this same study: Earlier menopause is associated with epigenetic age acceleration in women, but this is mitigated by hormone replacement therapy. \u00a0HRT modestly slows aging, as measured by the Horvath clock.)<\/span><\/p>\n

 <\/p>\n

Antagonistic Pleiotropy turned Upside Down<\/b><\/p>\n

So, what\u2019s going on? \u00a0My inclination is always to think in evolutionary terms.<\/span><\/p>\n

Antagonistic Pleiotropy<\/span><\/a> is the standard explanation for aging, though I have long argued that it doesn\u2019t fit the data. The theory says that some genes enhance fertility and survival early in life, but have detrimental effects late in life. \u00a0These genes are selected in a Darwinian process because their benefits outweigh their costs. Even though they die younger, those individuals carrying the pleiotropic genes leave more offspring, and that\u2019s what counts for evolution. \u00a0The crux of the theory is that nature is caught between Scylla and Charybdis, forced by limitations of the available genes to choose either high fertility with short lifespan or low fertility with longer lifespan.\u00a0 Crucial to the theory is the assumption that it is biologically impossible to separate the benefits of these pleiotropic genes (fertility) from their costs, so that there is no way evolution could engineer higher fertility without triggering later senescence.<\/span><\/p>\n

This theory was formulated by <\/span>George Williams in 1957<\/span><\/a>, long before anyone had heard of epigenetics.\u00a0 He assumed that if you have a gene, you\u2019re stuck with it for life. \u00a0We can\u2019t blame Williams for the frame of mind that he brought to the evolutionary question, but we now know that this is very much not the case. The body turns genes on and off in individual tissues and at specific times with exquisite precision. In fact, most of the euklaryotic genome is devoted not to genes, but to epigenetic controls of one kind or another.<\/span><\/p>\n

The fact is that genes are turned on that dial up fertility and promote robust replacement cell growth early in life, and aging at that time occurs quite slowly. \u00a0Later in life, these growth and fertility genes are dialed way back, and that is the era in which aging comes at us with a vengeance. This, to me, is a direct refutation of Antagonistic Pleiotropy as a theory.<\/span><\/p>\n

Nevertheless, many examples pleiotropic genes have been found in studies of aging. \u00a0The above story of telomerase seems to be a conspicuous example. Telomerase promotes epigenetic aging, while lack of telomerase promotes cellular senescence. \u00a0\u201cIf the \u2019gaitors don\u2019t getcha then the \u2019skeeters will.\u201d[<\/span>ref<\/span><\/a>]<\/span><\/p>\n

My interpretation of pleiotropy is in <\/span>my book<\/span><\/a> and some of my academic papers. \u00a0It is this: Aging has been built into our genomes by natural selection for the sake of the community. \u00a0Fixed lifespan, (especially when modified conditions of food stress) is helpful in preventing population overshoot that can lead to famines, epidemics, and extinction. \u00a0But whenever a trait is good for the community and bad for the individual, there is a temptation for the individual to cheat (\u201ccheating\u201d is actually the term used by evolutionary theorists). \u00a0In this case, cheating would mean evolving a longer lifespan via selfish genes that spread rapidly through the population, because they are more successful at the lowest level of Darwin\u2019s competition.<\/span><\/p>\n

Individual competition would erase aging if left unchecked. \u00a0The results would be great for individual fitness, but soon would be disastrous for the population. \u00a0Overpopulation would ensue, followed by the famines and epidemics mentioned above. Evolution has learned (over a very long expanse of time) to protect the communal interest, placing barriers in the way of individual selection for ever longer lifespan. \u00a0This is the evolutionary significance of pleiotropy. It provides that no simple mutation can substantially extend any aspect of lifespan without adversely affecting another aspect of lifespan or of fertility.\u00a0 The aging clock has been\u00a0\u201cpurposely\u201d configured so as to be spread out over several different mechanisms, tied not just to other pro-aging mechanisms but to fertility as well.\u00a0 Aging is hard to get rid of \u201cby design\u201d.<\/span><\/p>\n

In the standard theory that I don\u2019t believe, antagonistic pleiotropy is a precondition, and evolution has had to make the best of a bad deal. \u00a0In my version, antagonistic pleiotropy has been crafted by natural selection in its long-term mode. Limiting lifespan has been so important to the viability of the population that evolution has arranged to protect it from leaking away due to cheating, and antagonistic pleiotropy is one of the ways in which this is arranged. I have modeled this process in numerical simulations of evolution.<\/span><\/p>\n

My guess is that the connection between telomerase and epigenetic aging is an example of antagonistic pleiotropy in this latter sense–certainly not in the sense of Williams, because on their face telomerase and methylation have little to do with one another.<\/span><\/p>\n

 <\/p>\n

Bad news for life extension strategies<\/b><\/p>\n

But whatever the theoretical origins, the pleiotropic connection between telomerase and epigenetic aging complicates any strategy we might devise for slowing the progression of human aging. \u00a0<\/span><\/p>\n

I believe that the preponderance of evidence still indicates that activating telomerase has a net benefit for lifespan, but that probably we can add at most a few years by this route. \u00a0I think that epigenetics is much closer to the core, the origin of aging, and that interventions to modify epigenetic aging will eventually be our holy grail. The caveat is that telomeres are simple, but methylation is complicated, and methylation is just one of many epigenetic mechanisms.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

I have been enthusiastic about telomerase therapies for anti-aging since 2003. \u00a0But if I can\u2019t change my mind as new data appears, what\u2019s the point of being a scientist? \u00a0I still believe that lengthening telomeres is a net benefit, but the potential for added years is modest, and there are probably risks and tradeoffs. \u00a0The … Read more<\/a><\/p>\n","protected":false},"author":65,"featured_media":704,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-702","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nTelomerase: Update and Downgrade - Josh Mitteldorf<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telomerase: Update and Downgrade\" \/>\n<meta property=\"og:description\" content=\"I have been enthusiastic about telomerase therapies for anti-aging since 2003. \u00a0But if I can\u2019t change my mind as new data appears, what\u2019s the point of being a scientist? \u00a0I still believe that lengthening telomeres is a net benefit, but the potential for added years is modest, and there are probably risks and tradeoffs. \u00a0The ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/\" \/>\n<meta property=\"og:site_name\" content=\"Josh Mitteldorf\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-19T16:12:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-20T11:09:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png\" \/>\n\t<meta property=\"og:image:width\" content=\"875\" \/>\n\t<meta property=\"og:image:height\" content=\"453\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Josh Mitteldorf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Josh Mitteldorf\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/\"},\"author\":{\"name\":\"Josh Mitteldorf\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#\\\/schema\\\/person\\\/214c5d1dad9f15c48f03128d5cfccdb1\"},\"headline\":\"Telomerase: Update and Downgrade\",\"datePublished\":\"2018-03-19T16:12:14+00:00\",\"dateModified\":\"2018-03-20T11:09:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/\"},\"wordCount\":2758,\"commentCount\":163,\"publisher\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/03\\\/seesaw-min.png\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#respond\"]}],\"copyrightYear\":\"2018\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/\",\"url\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/\",\"name\":\"Telomerase: Update and Downgrade - Josh Mitteldorf\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/03\\\/seesaw-min.png\",\"datePublished\":\"2018-03-19T16:12:14+00:00\",\"dateModified\":\"2018-03-20T11:09:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#primaryimage\",\"url\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/03\\\/seesaw-min.png\",\"contentUrl\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/03\\\/seesaw-min.png\",\"width\":875,\"height\":453},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/2018\\\/03\\\/19\\\/telomerase-update-and-downgrade\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telomerase: Update and Downgrade\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#website\",\"url\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/\",\"name\":\"Josh Mitteldorf\",\"description\":\"Aging Matters\",\"publisher\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#organization\",\"name\":\"Josh Mitteldorf\",\"url\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/09\\\/1058476001.jpg\",\"contentUrl\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/09\\\/1058476001.jpg\",\"width\":864,\"height\":363,\"caption\":\"Josh Mitteldorf\"},\"image\":{\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/#\\\/schema\\\/person\\\/214c5d1dad9f15c48f03128d5cfccdb1\",\"name\":\"Josh Mitteldorf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d3a8498f3d727156673030716d233edc57840f110d501b1b523e1780e9043b92?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d3a8498f3d727156673030716d233edc57840f110d501b1b523e1780e9043b92?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d3a8498f3d727156673030716d233edc57840f110d501b1b523e1780e9043b92?s=96&d=mm&r=g\",\"caption\":\"Josh Mitteldorf\"},\"description\":\"Josh Mitteldorf studies evolutionary theory of aging using computer simulations. The surprising fact that our bodies are genetically programmed to age and to die offers an enormous opportunity for medical intervention. It may be that therapies to slow the progress of aging need not repair or regenerate anything, but only need to interfere with an existing program of self-destruction. Mitteldorf has taught a weekly yoga class for thirty years. He is an advocate for vigorous self care, including exercise, meditation and caloric restriction. After earning a PhD in astrophysicist, Mitteldorf moved to evolutionary biology as a primary field in 1996. He has taught at Harvard, Berkeley, Bryn Mawr, LaSalle and Temple University. He is presently affiliated with MIT as a visiting scholar. In private life, Mitteldorf is an advocate for election integrity as well as public health. He is an avid amateur musician, playing piano in chamber groups, French horn in community orchestras. His two daughters are among the first children adopted from China in the mid-1980s. Much to the surprise of evolutionary biologists, genetic experiments indicate that aging has been selected as an adaptation for its own sake. This poses a conundrum: the impact of aging on individual fitness is wholly negative, so aging must be regarded as a kind of evolutionary altruism. Unlike other forms of evolutionary altruism, aging offers benefits to the community that are weak, and not well focussed on near kin of the altruist. This makes the mechanism challenging to understand and to model. more at http:\\\/\\\/mathforum.org\\\/~josh\",\"sameAs\":[\"http:\\\/\\\/AgingAdvice.org\"],\"url\":\"https:\\\/\\\/scienceblog.com\\\/joshmitteldorf\\\/author\\\/joshmitteldorf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Telomerase: Update and Downgrade - Josh Mitteldorf","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/","og_locale":"en_US","og_type":"article","og_title":"Telomerase: Update and Downgrade","og_description":"I have been enthusiastic about telomerase therapies for anti-aging since 2003. \u00a0But if I can\u2019t change my mind as new data appears, what\u2019s the point of being a scientist? \u00a0I still believe that lengthening telomeres is a net benefit, but the potential for added years is modest, and there are probably risks and tradeoffs. \u00a0The ... Read more","og_url":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/","og_site_name":"Josh Mitteldorf","article_published_time":"2018-03-19T16:12:14+00:00","article_modified_time":"2018-03-20T11:09:02+00:00","og_image":[{"width":875,"height":453,"url":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png","type":"image\/png"}],"author":"Josh Mitteldorf","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Josh Mitteldorf","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#article","isPartOf":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/"},"author":{"name":"Josh Mitteldorf","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#\/schema\/person\/214c5d1dad9f15c48f03128d5cfccdb1"},"headline":"Telomerase: Update and Downgrade","datePublished":"2018-03-19T16:12:14+00:00","dateModified":"2018-03-20T11:09:02+00:00","mainEntityOfPage":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/"},"wordCount":2758,"commentCount":163,"publisher":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#organization"},"image":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#primaryimage"},"thumbnailUrl":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#respond"]}],"copyrightYear":"2018","copyrightHolder":{"@id":"https:\/\/scienceblog.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/","url":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/","name":"Telomerase: Update and Downgrade - Josh Mitteldorf","isPartOf":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#website"},"primaryImageOfPage":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#primaryimage"},"image":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#primaryimage"},"thumbnailUrl":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png","datePublished":"2018-03-19T16:12:14+00:00","dateModified":"2018-03-20T11:09:02+00:00","breadcrumb":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#primaryimage","url":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png","contentUrl":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png","width":875,"height":453},{"@type":"BreadcrumbList","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/2018\/03\/19\/telomerase-update-and-downgrade\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/scienceblog.com\/joshmitteldorf\/"},{"@type":"ListItem","position":2,"name":"Telomerase: Update and Downgrade"}]},{"@type":"WebSite","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#website","url":"https:\/\/scienceblog.com\/joshmitteldorf\/","name":"Josh Mitteldorf","description":"Aging Matters","publisher":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/scienceblog.com\/joshmitteldorf\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#organization","name":"Josh Mitteldorf","url":"https:\/\/scienceblog.com\/joshmitteldorf\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#\/schema\/logo\/image\/","url":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2024\/09\/1058476001.jpg","contentUrl":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2024\/09\/1058476001.jpg","width":864,"height":363,"caption":"Josh Mitteldorf"},"image":{"@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/scienceblog.com\/joshmitteldorf\/#\/schema\/person\/214c5d1dad9f15c48f03128d5cfccdb1","name":"Josh Mitteldorf","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d3a8498f3d727156673030716d233edc57840f110d501b1b523e1780e9043b92?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d3a8498f3d727156673030716d233edc57840f110d501b1b523e1780e9043b92?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d3a8498f3d727156673030716d233edc57840f110d501b1b523e1780e9043b92?s=96&d=mm&r=g","caption":"Josh Mitteldorf"},"description":"Josh Mitteldorf studies evolutionary theory of aging using computer simulations. The surprising fact that our bodies are genetically programmed to age and to die offers an enormous opportunity for medical intervention. It may be that therapies to slow the progress of aging need not repair or regenerate anything, but only need to interfere with an existing program of self-destruction. Mitteldorf has taught a weekly yoga class for thirty years. He is an advocate for vigorous self care, including exercise, meditation and caloric restriction. After earning a PhD in astrophysicist, Mitteldorf moved to evolutionary biology as a primary field in 1996. He has taught at Harvard, Berkeley, Bryn Mawr, LaSalle and Temple University. He is presently affiliated with MIT as a visiting scholar. In private life, Mitteldorf is an advocate for election integrity as well as public health. He is an avid amateur musician, playing piano in chamber groups, French horn in community orchestras. His two daughters are among the first children adopted from China in the mid-1980s. Much to the surprise of evolutionary biologists, genetic experiments indicate that aging has been selected as an adaptation for its own sake. This poses a conundrum: the impact of aging on individual fitness is wholly negative, so aging must be regarded as a kind of evolutionary altruism. Unlike other forms of evolutionary altruism, aging offers benefits to the community that are weak, and not well focussed on near kin of the altruist. This makes the mechanism challenging to understand and to model. more at http:\/\/mathforum.org\/~josh","sameAs":["http:\/\/AgingAdvice.org"],"url":"https:\/\/scienceblog.com\/joshmitteldorf\/author\/joshmitteldorf\/"}]}},"jetpack_featured_media_url":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-content\/uploads\/sites\/2\/2018\/03\/seesaw-min.png","jetpack_shortlink":"https:\/\/wp.me\/pgtN8h-bk","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/posts\/702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/users\/65"}],"replies":[{"embeddable":true,"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/comments?post=702"}],"version-history":[{"count":0,"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/posts\/702\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/media\/704"}],"wp:attachment":[{"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/media?parent=702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/categories?post=702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scienceblog.com\/joshmitteldorf\/wp-json\/wp\/v2\/tags?post=702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}